PerkinElmer Inc. provides products, services, and solutions to the diagnostics, research, environmental, industrial, and laboratory services markets worldwide. The company operates through two segments, Human Health and Environmental Health. The company was founded in 1931 and is based in Waltham, Massachusetts.
PKI Price Forecast Based on DCF Valuation
DCF Fair Value Target:
Below please find a table outlining a discounted cash flow forecast for PKI, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Perkinelmer Inc ranked in the 19th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. As for the metrics that stood out in our discounted cash flow analysis of Perkinelmer Inc, consider:
79% of the company's capital comes from equity, which is greater than 64.2% of stocks in our cash flow based forecasting set.
The weighted average cost of capital for the company is 7. This value is greater than just 20.46% stocks in the Healthcare sector that generate free cash flow.
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
DHR, HAE, PPD, AZN, and CNC can be thought of as valuation peers to PKI, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.